| Term | Count | % | | DRUG INEFFECTIVE | 4070 | 9.07% |
| TREATMENT FAILURE | 3077 | 6.86% |
| OCULAR HYPERAEMIA | 2333 | 5.20% |
| EYE IRRITATION | 1842 | 4.11% |
| MADAROSIS | 1386 | 3.09% |
| EYE PRURITUS | 1320 | 2.94% |
| ERYTHEMA OF EYELID | 1012 | 2.26% |
| EYE PAIN | 937 | 2.09% |
| HYPERSENSITIVITY | 851 | 1.90% |
| VISION BLURRED | 836 | 1.86% |
| INTRAOCULAR PRESSURE INCREASED | 715 | 1.59% |
| FATIGUE | 705 | 1.57% |
| OFF LABEL USE | 701 | 1.56% |
| HEADACHE | 674 | 1.50% |
| DRY EYE | 647 | 1.44% |
| EYE SWELLING | 646 | 1.44% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 583 | 1.30% |
| DYSPNOEA | 543 | 1.21% |
| INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION | 539 | 1.20% |
| EYELIDS PRURITUS | 530 | 1.18% |
| DIZZINESS | 518 | 1.15% |
| ERYTHEMA | 510 | 1.14% |
| NAUSEA | 506 | 1.13% |
| DIARRHOEA | 496 | 1.11% |
| INCORRECT DOSE ADMINISTERED | 494 | 1.10% |
| SKIN HYPERPIGMENTATION | 480 | 1.07% |
| FALL | 467 | 1.04% |
| VISUAL IMPAIRMENT | 458 | 1.02% |
| ASTHENIA | 444 | 0.99% |
| PRURITUS | 422 | 0.94% |
| EYELID OEDEMA | 419 | 0.93% |
| WRONG TECHNIQUE IN DRUG USAGE PROCESS | 404 | 0.90% |
| PAIN | 398 | 0.89% |
| DEATH | 378 | 0.84% |
| LACRIMATION INCREASED | 376 | 0.84% |
| EYELID IRRITATION | 373 | 0.83% |
| PRODUCT DOSE OMISSION ISSUE | 357 | 0.80% |
| RASH | 351 | 0.78% |
| CATARACT | 337 | 0.75% |
| INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION | 329 | 0.73% |
| GLAUCOMA | 324 | 0.72% |
| MALAISE | 320 | 0.71% |
| EYE DISCHARGE | 305 | 0.68% |
| THERAPEUTIC RESPONSE DECREASED | 300 | 0.67% |
| GROWTH OF EYELASHES | 295 | 0.66% |
| SKIN DISCOLOURATION | 291 | 0.65% |
| PNEUMONIA | 286 | 0.64% |
| VISUAL ACUITY REDUCED | 285 | 0.64% |
| TRICHORRHEXIS | 281 | 0.63% |
| BLEPHARAL PIGMENTATION | 279 | 0.62% |
| ARTHRALGIA | 277 | 0.62% |
| VOMITING | 273 | 0.61% |
| DRUG DOSE OMISSION | 272 | 0.61% |
| PAIN IN EXTREMITY | 266 | 0.59% |
| COUGH | 264 | 0.59% |
| DRUG HYPERSENSITIVITY | 264 | 0.59% |
| WEIGHT DECREASED | 259 | 0.58% |
| ACCIDENTAL EXPOSURE TO PRODUCT | 250 | 0.56% |
| INSOMNIA | 245 | 0.55% |
| PRODUCT QUALITY ISSUE | 239 | 0.53% |
| HYPERTENSION | 235 | 0.52% |
| EYE DISORDER | 223 | 0.50% |
| FOREIGN BODY SENSATION IN EYES | 213 | 0.47% |
| DECREASED APPETITE | 206 | 0.46% |
| BLOOD PRESSURE INCREASED | 201 | 0.45% |
| CONSTIPATION | 200 | 0.45% |
| OCULAR DISCOMFORT | 195 | 0.43% |
| PRODUCT PACKAGING QUANTITY ISSUE | 195 | 0.43% |
| BACK PAIN | 194 | 0.43% |
| GAIT DISTURBANCE | 189 | 0.42% |
| ANAEMIA | 188 | 0.42% |
| HAIR GROWTH ABNORMAL | 188 | 0.42% |
| ANXIETY | 187 | 0.42% |
| HYPOTENSION | 184 | 0.41% |
| CONDITION AGGRAVATED | 179 | 0.40% |
| PYREXIA | 175 | 0.39% |
| URINARY TRACT INFECTION | 175 | 0.39% |
| PHOTOPHOBIA | 174 | 0.39% |
| FEELING ABNORMAL | 170 | 0.38% |
| DEPRESSION | 159 | 0.35% |
| PERIPHERAL SWELLING | 159 | 0.35% |
| CONFUSIONAL STATE | 158 | 0.35% |
| SWELLING OF EYELID | 158 | 0.35% |
| BLINDNESS | 157 | 0.35% |
| MYALGIA | 155 | 0.35% |
| SOMNOLENCE | 154 | 0.34% |
| EXPIRED PRODUCT ADMINISTERED | 153 | 0.34% |
| ABDOMINAL DISCOMFORT | 152 | 0.34% |
| CHEST PAIN | 150 | 0.33% |
| ATRIAL FIBRILLATION | 149 | 0.33% |
| DRUG ADMINISTERED AT INAPPROPRIATE SITE | 148 | 0.33% |
| EYELID PAIN | 148 | 0.33% |
| NASOPHARYNGITIS | 148 | 0.33% |
| CEREBROVASCULAR ACCIDENT | 147 | 0.33% |
| OEDEMA PERIPHERAL | 147 | 0.33% |
| NO ADVERSE EVENT | 146 | 0.33% |
| ALOPECIA | 144 | 0.32% |
| BLOOD GLUCOSE INCREASED | 143 | 0.32% |
| WEIGHT INCREASED | 143 | 0.32% |
| BURNING SENSATION | 141 | 0.31% |
| Total | 44869 | |